3Furlanetto RW, Underwood LE, Van Wvk J J, et al. Estimation of somatomedin-C levels in normals and patients with pituitary disease by radioimmunoassay. J Clin Invest, 1977,60(3) :648-657.
8Turktas I, Ozkaya O, Bostanci I, et al. Safety of inhaled corticosteroid therapy in young children with asthma. Ann Allergy Immunol, 2001,86 (6): 649-654.
9Norjavaara E, Gerhardsson De Verdier M, Lindmark B.Reduced height in Swedish men with asthma at the age of conscription for military service. J Pediatr,2000,137 (1) :25-29.
5Hoshino M, Nakamura Y, Sire JJ. Expression of growth factors and remodeling of the airway wall in bronchial asthman. Thorax 1998;53(1) :21.
6Oymada H,Kayaba H,Kamach Y,et al.An optimal condition of bronchial cell proliferation stimulated by insulin-like growth factor- I .Int Arch Allergy Immunol 2000;122(suppl):59.
7Hoshino M, Nakamura Y,Sim JJ,et al. Inhaled corticosteroid reduced lamina reticularis of the basement membrane by modulation of insulin-like growth factor(IGF-I) expression in bronchial asthma.Clin Exp Allergy 1998;28(5) :568.
8Jean AL, Clifford JR, Marjolein V,et al. Association between insulin- like growth factor- I and bone mineral density in older women and men:The Framingham heart study. J Clin Endocrinol Metab 1998;83(12):4257.
9Ranke MB. Diagnostics of Endocrine function in children and adolescents. Basel :Karger , 2003.
10Ranke MB, Feldt-Rasmussen U, Bang P, et al. How should insulinlike growth factor I be measured? a consensus statement. Horm Res.2001,55 Suppl 2:106-109.
